M
Mereo BioPharma Group plc D
D
MREO
2.73000
USD
-0.10
(-3.53%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-8
حجم السوق
434,070,789
الأخبار المقالات
العنوان: Mereo BioPharma Group plc
القطاع: Healthcare
الصناعة: Biotechnology
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its tworare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).